Nanocarriers as an emerging platform for cancer therapy
Dan PeerDepartment of Anesthesia, Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USAJeffrey M. KarpDepartment of Medicine, HST Center for Biomedical Engineering, Brigham and Women's Hospital, Harvard Medical School, Cambridge, 02139, Massachusetts, USASeungpyo HongDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, 02139, Massachusetts, USAOmid C. FarokhzadLaboratory of Nanomedicine and Biomaterials and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, 02115, Massachusetts, USARimona MargalitDepartment of Biochemistry, George S. Wise Faculty of Life Sciences, and the Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, 69978, IsraelRóbert LangerDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, 02139, Massachusetts, USA
2007en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 5Использованных источников: 0